EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Inhibition of XPO1 by selinexor enhances terminal erythroid maturation through modulation of HSP70 trafficking in severe β0-thalassemia/HbE

Pinyaphat Khamphikham iD, Adisak Tantiworawit iD, Songyot Anuchapreeda iD

PLOS One · 2025

DOI: 10.1371/journal.pone.0333127 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Pinyaphat Khamphikham und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Clinical Microscopy, Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailan…. Hauptthemen laut MEDLINE: beta-Thalassemia, Erythropoiesis, Exportin 1 Protein, Hydrazines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Office of the Permanent Secretary, Ministry of Higher Education, Science, Research and Innovation (OPS MHESI), Thailand Science Research and Innovation (TSRI), Chiang Mai University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ineffective erythropoiesis is a hallmark of β-thalassemia, characterized by impaired erythroid maturation and increased apoptosis of erythroid precursors in the bone marrow, resulting in chronic anemia. Heat shock protein 70 (HSP70) trafficking has emerged as a critical regulator of erythroid maturation. Inhibition of nuclear export protein exportin-1 (XPO1) retains HSP70 in the nucleus, thereby promoting terminal erythroid maturation (TEM) through stabilization of the transcription factor GATA1. In this study, we screened nine XPO1 inhibitors, including the natural compounds curcumin, piperlongumine, plumbagin, and oridonin, as well as the synthetic agents KPT-185, KPT-276, selinexor, verdinexor, and eltanexor, in erythroid progenitors from patients with severe β 0 -thalassemia/HbE to identify the most effective inducer of TEM and to investigate the downstream molecular mechanisms involved. Selinexor, an FDA-approved drug for multiple myeloma, showed the greatest efficacy in enhancing TEM across nine independent patient samples without altering hemoglobin composition. Combination treatments with hydroxyurea (a γ-globin inducer) and SIS3 (a SMAD3 inhibitor) confirmed selinexor’s dominant effect. Mechanistically, selinexor-induced TEM was associated not only with stabilization of nuclear HSP70 and GATA1 but also with a dose-dependent increase in cytoplasmic HSP70. These findings suggest that cytoplasmic HSP70 trafficking may contribute to erythroid maturation in severe β 0 -thalassemia/HbE, implicating regulatory pathways beyond nuclear GATA1 stabilization. Collectively, our findings highlight the therapeutic potential of repurposing selinexor to enhance erythroid maturation in β-thalassemia and suggest that cytoplasmic HSP70 trafficking warrants further investigation as a contributor to terminal erythroid maturation in β-thalassemia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

beta-ThalassemiaErythropoiesisExportin 1 ProteinHydrazinesTriazolesErythroid Precursor CellsHumansMaleFemaleYoung AdultAdultPrimary Cell CultureHSP70 Heat-Shock ProteinsProtein TransportGATA1 Transcription FactorCell NucleusDrug Evaluation, PreclinicalCytoplasmHemoglobin Ebeta-GlobinsHematinics

Substanzen

XPO1 protein, humanExportin 1 ProteinHSP70 Heat-Shock ProteinsselinexorHydrazinesTriazolesGATA1 Transcription FactorHemoglobin Ebeta-GlobinsHematinics

Autor:innen und Institutionen

  • Division of Clinical Microscopy, Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand.
  • Hematology and Health Technology Research Center, Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand.
  • Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.

ORCID-Profile: Pinyaphat Khamphikham, Adisak Tantiworawit, Songyot Anuchapreeda

Förderung

  • Office of the Permanent Secretary, Ministry of Higher Education, Science, Research and Innovation (OPS MHESI)
  • Thailand Science Research and Innovation (TSRI)
  • Chiang Mai University
  • Office of the Permanent Secretary, Ministry of Higher Education, Science, Research and Innovation (OPS MHESI), Thailand Science Research and Innovation (TSRI)…

Zitieren

APA

Khamphikham, P., Tantiworawit, A., & Anuchapreeda, S. (2025). Inhibition of XPO1 by selinexor enhances terminal erythroid maturation through modulation of HSP70 trafficking in severe β0-thalassemia/HbE. PLOS One. https://doi.org/10.1371/journal.pone.0333127

Vancouver

Khamphikham P, Tantiworawit A, Anuchapreeda S. Inhibition of XPO1 by selinexor enhances terminal erythroid maturation through modulation of HSP70 trafficking in severe β0-thalassemia/HbE. PLOS One. 2025. doi:10.1371/journal.pone.0333127

BibTeX
@article{Khamphikham2025,
  author = {Khamphikham, Pinyaphat and Tantiworawit, Adisak and Anuchapreeda, Songyot},
  title = {Inhibition of XPO1 by selinexor enhances terminal erythroid maturation through modulation of HSP70 trafficking in severe β0-thalassemia/HbE},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0333127}
}
Kostenlos starten →